— Know what they know.
Not Investment Advice
Also trades as: ABVX.PA (PAR) · $vol 25M · 0RA9.L (LSE) · $vol 1M · AAVXF (OTC) · $vol 0M

ABVX Earnings

Abivax S.A.
1W: -6.0% 1M: -10.2% 3M: -26.8% YTD: -35.0% 1Y: -4.1% 3Y: +948.2%
$87.00
+0.50 (+0.58%)
 
Weekly Expected Move ±7.2%
$75 $82 $88 $94 $101
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 34 · $7.6B mcap · 79M float · 1.75% daily turnover · Short 37% of daily vol
Credit Risk of going bust: lower than 81% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), Abivax S.A. would be worth roughly what it owes.
Total debt $1.3M against a stock market value of $7.62B.
Distance to default 9.87 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $674K (short-term plus half of long-term), stock volatility 90.8%; Altman Z'' -2.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Last Earnings 2026-09-21
EPS
€-1.71 (US$-1.90)
▼ Miss -75.3%
Revenue
€1M ($2M)
▲ Beat +71.8%
Next Earnings 2026-12-21
EPS Estimate
€-1.24 (US$-1.38)
Range: €-1.55 - €-0.94
Revenue Estimate
€591K ($657K)
3 analysts
1 USD = 0.90 EUR

Estimate vs Actual

Earnings Surprise History

2/18
EPS Beats
5/18
Revenue Beats
11%
EPS Beat Rate
28%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-22 annual 2030-12-31 €8.58 €8.58 — €1,502,594,608 €1,721,507,660
2026-10-22 annual 2026-12-31 €-3.64 €-3.64 — €4,184,211 €4,210,248
2026-10-22 annual 2027-12-31 €-3.44 €-3.44 — €46,449,915 €74,064,732
2026-10-22 annual 2028-12-31 €-1.37 €-1.37 — €333,355,345 €413,517,152
2026-10-22 annual 2029-12-31 €3.03 €3.03 — €853,644,169 €1,016,900,461
2026-10-21 annual 2030-12-31 €8.59 €8.58 ▼ 0.01 €1,505,177,999 €1,502,594,608
2026-10-21 annual 2028-12-31 €-1.39 €-1.37 ▲ 0.02 €336,011,240 €333,355,345
2026-10-21 quarter 2026-12-30 €-1.26 €-1.24 ▲ 0.02 €590,747 €590,747
2026-10-21 annual 2027-12-31 €-3.58 €-3.44 ▲ 0.14 €46,554,797 €46,449,915
2026-10-21 annual 2026-12-31 €-3.65 €-3.64 ▲ 0.01 €3,871,418 €4,184,211
2026-10-21 quarter 2027-06-30 €-1.35 €-1.33 ▲ 0.02 €590,747 €590,747
2026-10-21 annual 2029-12-31 €3.76 €3.03 ▼ 0.73 €901,050,559 €853,644,169
2026-10-20 annual 2027-12-31 €-3.67 €-3.58 ▲ 0.09 €46,554,797 €46,554,797
2026-10-20 annual 2026-12-31 €-3.74 €-3.65 ▲ 0.09 €3,871,418 €3,871,418
2026-10-20 annual 2028-12-31 €-1.42 €-1.39 ▲ 0.03 €336,011,240 €336,011,240
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms